• Ticker:- BBH;false;MVBBH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Biotech ETF BBH

  • Full Name: Market Vectors®
    Biotech ETF (BBH)

    Management Style: Replication

    Underlying Index: Market Vectors® US Listed Biotech 25 Index (MVBBHTR)

    Index Description: MVBBHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 03/30/15

    • 30-Day SEC Yield1

      -0.10%
    • Total Net Assets

      $797.4M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/18/2015
  • Portfolio Composition (%)
    as of 03/30/15

    • % of Net Assets
    • Stocks

      100.10
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.10
  • Download All HoldingsAll Holdings (%) as of 03/30/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Gilead Sciences Inc
    GILD US
    1,091,034
    109,856,21313.78
    Amgen Inc
    AMGN US
    586,772
    96,409,57312.09
    Celgene Corp
    CELG US
    724,929
    87,005,97910.91
    Biogen Idec Inc
    BIIB US
    159,927
    69,027,6928.66
    Regeneron Pharmaceuticals Inc
    REGN US
    91,099
    41,885,4985.25
    Biomarin Pharmaceutical Inc
    BMRN US
    304,137
    39,274,7324.93
    Alexion Pharmaceuticals Inc
    ALXN US
    194,668
    35,090,8544.40
    Vertex Pharmaceuticals Inc
    VRTX US
    283,826
    34,413,9034.32
    Illumina Inc
    ILMN US
    182,976
    34,329,9574.31
    Medivation Inc
    MDVN US
    246,534
    33,020,7644.14
    Incyte Corp Ltd
    INCY US
    314,078
    29,583,0073.71
    Pharmacyclics Inc
    PCYC US
    115,339
    29,576,3803.71
    United Therapeutics Corp
    UTHR US
    118,009
    20,865,1712.62
    Alnylam Pharmaceuticals Inc
    ALNY US
    189,002
    20,370,6362.55
    Qiagen Nv
    QGEN US
    690,105
    17,625,2822.21
    Isis Pharmaceuticals Inc
    ISIS US
    245,409
    15,904,9571.99
    Alkermes Plc
    ALKS US
    230,430
    14,406,4841.81
    Grifols Sa
    GRFS US
    401,744
    13,486,5461.69
    Puma Biotechnology Inc
    PBYI US
    49,672
    11,909,3591.49
    Charles River Laboratories Internationa
    CRL US
    125,202
    9,994,8761.25
    Intercept Pharmaceuticals Inc
    ICPT US
    30,823
    9,120,8341.14
    Cepheid Inc
    CPHD US
    158,049
    8,742,4801.10
    Seattle Genetics Inc
    SGEN US
    164,444
    5,936,4280.74
    Mannkind Corp
    MNKD US
    986,156
    5,256,2110.66
    Myriad Genetics Inc
    MYGN US
    144,813
    5,120,5880.64
    Other/Cash
    -819,940-0.10
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.